Ordering
Available Variants100 mg
CHJ.55048-100mg
Price
€100.80
Available – Dispatch in 14 days
250 mg
CHJ.55048-250mg
Price
€177.60
Available – Dispatch in 14 days
1 g
CHJ.55048-1g
Price
€535.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHJ.55048-100mg | €100.80 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
250 mg | CHJ.55048-250mg | €177.60 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 g | CHJ.55048-1g | €535.20 |
≥95% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C38H69NO13 |
|---|---|
| CAS Number | 81103-11-9 |
| Molecular Weight | 747.95 |
| NACRES | NA.76 |
| PubChem Substance ID | 329775082 |
| UNSPSC Code | 51102829 |
| MDL number | MFCD00865140 |
Safety Information Handling visibility
| pictograms |
GHS07
 GHS07
|
|---|---|
| signalword | Warning |
| hcodes | H302 |
| pcodes | P264 - P270 - P301 + P312 - P501 |
| Hazard Classifications | Acute Tox. 4 Oral |
| Storage Class | 11 - Combustible Solids |
| wgk | WGK 1 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | dust mask type N95 (US), Eyeshields, Gloves |
Technical Overview & Applications Use-case context
Clarithromycin, with a Chemical Abstracts Service (CAS) registry number of 81103-11-9, is a semi-synthetic macrolide antibiotic derived from erythromycin. It exhibits a broad spectrum of antimicrobial activity against various Gram-positive and Gram-negative bacteria. Clarithromycin functions by inhibiting protein synthesis through binding to the bacterial ribosome, thereby preventing the translation of messenger RNA into proteins essential for bacterial growth and replication. This mechanism of action renders clarithromycin effective against a range of bacterial infections, including those affecting the respiratory tract, skin, and soft tissues. The drug is commonly prescribed for conditions such as pneumonia, bronchitis, and sinusitis, and is also used in combination with other medications for the treatment of certain gastrointestinal infections and diseases, including Helicobacter pylori infections. Its pharmacokinetic properties allow for oral administration and once- or twice-daily dosing.
